QuarterHawk — Equity ResearchQuarterHawk — Equity Research

Afya Limited (AFYA)

Consumer Defensive

Actionable
Fundamental
4
Sentiment
4
Technical
4

Buy limit 14.16 — pullback to the 10-07/10-08 base-top retest (10-08 high 14.16) in a trend-aligned V-reversal above SMA50/SMA200; protective stop 13.62 (1.0xATR below entry, under swingLow 13.77); targets 15.24 / 16.05; R/R 2.00; GTC. Breakout buy-stop alternative screened and rejected (R/R <= 0.98 < 1.0).

Analysis as of 2026-10-09· more than 2 trading days ago

Company overview

Afya Limited is a leading provider of medical education in Brazil, offering a range of educational products and services focused on the medical field. The company operates medical schools, preparatory courses, and advanced graduate studies, and provides digital health services through a subscription-based platform. Afya also offers programs in various health sciences and other academic disciplines.

Fundamental

good
Fundamental4
Solid value setup

Afya exhibits strong profitability and cash generation with low valuation multiples, despite some regulatory and governance risks.

Afya pairs strong margins and cash generation with low valuation multiples (P/E 8.22, EV/EBITDA 5.26, free-cash-flow yield 17.88%). SEC disclosures emphasize dependence on Brazilian medical-education regulation and controlling-shareholder governance, but the latest interim filing indicates solid liquidity and no disclosed covenant issues. Overall this reads as a solid value + quality setup with some country/governance overhang.

Sentiment

good
Sentiment4
Positive merger sentiment

The recent merger announcement with Yduqs has been received positively, enhancing sentiment around the stock.

Dominant short-term driver is the Afya–Yduqs merger agreement announced 2026-09-24 (confidence: announced), received net-positive by in-window coverage (scored +0.4; Afya holders to own 69% of the combined company), alongside an announced MEC medical-seat approval scored +0.3. The 14-day scoring window measures mildly positive (aggregate ≈ +0.12 across 6 scored items) while the numeric sentiment delta is indeterminate (baseline had no scorable on-topic items) with an item-level improving read; Red-Flag Screen clean.

Technical

good
Technical4
V-reversal breakout

The stock has V-reversed above key moving averages, indicating a strong upward momentum.

AFYA has V-reversed +27% off the 2026-09-29 low (11.62), reclaiming the SMA50 (13.76) and SMA200 (14.31) and closing 2026-10-09 at 14.75 (+4.2%, day high 14.76) with the short-term moving-average stack aligned up: price above SMA20/50/200, EMA9 13.62 > EMA21 13.48, above WMA9/21, DEMA14 13.62 and TEMA14 14.00 (10-09 VWAP 14.49). RSI14 65.4 rising, Williams %R -0.3 at the range top, MACD histogram +0.23 expanding with the line crossing zero, and ADX14 26.6 rising (>25) — momentum confirms the trend. One soft spot: the 10-09 push came on below-average volume (264k vs ~500k recent average). Plan: buy the first pullback — limit 14.16 at the 10-08 base top / breakout-retest shelf — stop 13.62 (1.0x ATR floor beneath the 13.77 swing low), targets 15.24/16.05, R/R 2.00. The breakout buy-stop alternative was screened and rejected (R/R <= 0.98).

You’re looking at 2026-10-09 — more than 2 trading days ago.

Subscribers saw this then, and see today’s score, verdict and trade plan now.

Not financial advice. For informational and educational purposes only.